pimobendan


Also found in: Wikipedia.

pimobendan

phosphodiesterase inhibitor used for its positive inotropic effect and vasodilation in management of heart failure in dogs.
References in periodicals archive ?
Rector TS, Cohn JN (1992) Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan.
Abstract: Pimobendan is a phosphodiesterase (PDE) inhibitor and calcium sensitizer with inotropic, lusitropic, and rasodilator properties used in the treatment of congestive heart failure.
Key words: pimobendan, pharmacokinetic, inotropic, psittacine, congestive heart failure, avian, Hispaniolan Amazon parrots, Amazona ventralis
Quality of Life and Extension of Survival Time, Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: The QUEST study.
Medicamentos: la incorporacion temprana de medicamentos como espironolactona o pimobendan han mostrado un mayor tiempo de sobrevida (6,12).
Actualmente el uso del pimobendan es una alternativa medica efectiva en la evolucion de los animales con EVD (3).
Influence of levosimendan, pimobendan, and milrinone on the regional distribution of cardiac output in anaesthetized dogs.
The effects of levosimendan on the regional distribution of cardiac output compared to pimobendan and milrinone have been studied in anaesthetised dogs (94).
Beneficial effects of pimobendan on exercise tolerance and quality of life in patients with heart failure: Results of a multicenter trial.
Assessment of patient outcome with the Minnesota living with heart failure questionnaire: reliability and validity during randomized, double-blind, placebo-controlled trial of pimobendan.
New data were also presented at the 29th World Veterinary Congress that show that dogs with congestive heart failure (CHF) that is due to a condition called myxomatous mitral valve disease (MMVD) live longer when treated with pimobendan (Vetmedin(R)) compared with a commonly used ACE inhibitor(3).
Both the capsules and chewable tablets contain the same pharmaceutical ingredient, pimobendan, and are considered equivalent for clinical use.